Demonstrates improved photovoltaic performance in perovskite solar cells using MoS2, suggesting enhanced stability and efficiency.
High Resolution Image Download MS PowerPoint Slide Perovskite solar cells have achieved rapid efficiency gains; however, interfacial recombination and energy-level mismatch remain major factors limiting performance consistency and stability. This work presents a systematic numerical investigation of interface engineering in perovskite solar cells using SCAPS-1D simulations. Three absorber materials of methylammonium lead iodide (MAPbI 3 ), formamidinium lead iodide (FAPbI 3 ), and cesium lead iodide (CsPbI 3 ) are examined within an identical device configuration employing TiO 2 as the electron transport layer and spiro-OMeTAD as the hole transport layer. A thin molybdenum disulfide (MoS 2 ) layer is introduced between the absorber and the hole transport layer to evaluate its influence on the band alignment, electric potential distribution, and photovoltaic performance. The results show that MoS 2 modifies the valence band alignment at the back interface, increasing the local electric potential and supporting an improved charge separation. Devices incorporating MoS 2 exhibit enhanced short-circuit current density, fill factor, and power conversion efficiency across all absorber compositions. Efficiency improvements from 19.28% to 21.54% for MAPbI 3, from 20.10% to 22.25% for FAPbI 3, and from 15.32% to 18.25% for CsPbI 3 were observed. Parametric analyses further indicate an improved tolerance to variations in absorber thickness, doping concentration, temperature, and bulk defect density in MoS 2 -integrated structures. These findings demonstrate that MoS 2 -based interface modification offers a consistent pathway to reduce interfacial losses and improve the photovoltaic performance across hybrid and all-inorganic perovskite solar cells.
No takes yet. Share an insight, caveat, or question.
Noman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: